Navigating the challenge of tumor heterogeneity in cancer therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Discovery

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2159-8290.CD-13-1042PMID 24501303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Addressing genetic tumor heterogeneity through computationally predictive combination therapy.

  2013cited by this paper
• The causes and consequences of genetic heterogeneity in cancer evolution

  2013cited by this paper
• Defining principles of combination drug mechanisms of action

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

  2012cited by this paper
• High drug attrition rates—where are we going wrong?

  2011cited by this paper
• A mammalian functional-genetic approach to characterizing cancer therapeutics.

  2010cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer

  1975cited by this paper

• Endometrial cancer: from clinical reality to molecular treatment

  2025cites this paper
• Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions

  2025cites this paper
• From silent partners to potential therapeutic targets: macrophages in colorectal cancer

  2025cites this paper
• Demystifying EV heterogeneity: emerging microfluidic technologies for isolation and multiplexed profiling of extracellular vesicles.

  2025cites this paper
• Relatively Rare Populations of Invasive Cells Drive Progression of Heterogeneous Tumors

  2024influential citation
• Predicting drug response through tumor deconvolution by cancer cell lines

  2024cites this paper
• Intelligent nanocatalyst mediated lysosomal ablation pathway to coordinate the amplification of tumor treatment

  2024cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• Cell Electrokinetic Fingerprint: A Novel Approach Based on Optically Induced Dielectrophoresis (ODEP) for In‐Flow Identification of Single Cells

  2024cites this paper
• Alum-tuned hyaluronic acid-based hydrogel with immune checkpoint inhibition for immunophoto therapy of cancer.

  2023cites this paper
• Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

  2023cites this paper
• Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

  2023cites this paper
• In search of cytotoxic abietyl amides

  2023cites this paper
• Cell facilitation promotes growth and survival under drug pressure in breast cancer

  2023cites this paper
• Hepatocellular Carcinoma: The Role of MicroRNAs

  2022cites this paper
• Defining Multiple Layers of Intratumor Heterogeneity Based on Variations of Perturbations in Multi-omics Profiling

  2022cites this paper
• Evaluation of a Radio-IMmunoStimulant (RIMS) in a Syngeneic Model of Murine Prostate Cancer and ImmunoPET Analysis of T-cell Distribution.

  2022cites this paper
• Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity

  2022cites this paper
• Near-infrared light–triggered platelet arsenal for combined photothermal-immunotherapy against cancer

  2021cites this paper
• Quantitation of amiodarone and N-desethylamiodarone in single HepG2 cells by single-cell printing-liquid vortex capture-mass spectrometry

  2021cites this paper
• Ecological interactions in breast cancer: Cell facilitation promotes growth and survival under drug pressure

  2021cites this paper
• Mapping Spatial Genetic Landscapes in Tissue Sections through Microscale Integration of Sampling Methodology into Genomic Workflows.

  2021cites this paper
• Facilitation drives estrogen receptor positive (ER+) breast cancer growth and survival under drug pressure Authors:

  2021cites this paper
• Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy

  2020cites this paper
• Kernel Fusion Method for Detecting Cancer Subtypes via Selecting Relevant Expression Data

  2020cites this paper
• A deep learning and similarity-based hierarchical clustering approach for pathological stage prediction of papillary renal cell carcinoma

  2020cites this paper
• Isolation and Analysis of Tumor Cell Subpopulations Using Biomimetic Immuno‐Fluorescent Magnetic Multifunctional Nanoprobes

  2020cites this paper
• Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)

  2019cites this paper
• Dietary phytochemicals with anti-oxidant and pro-oxidant activities: A double-edged sword in relation to adjuvant chemotherapy and radiotherapy?

  2019cites this paper
• The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma

  2019cites this paper
• Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator

  2019cites this paper
• Development of Optical Metabolic Imaging for Pancreatic and Breast Cancer Precision Medicine

  2019cites this paper
• A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform

  2019cites this paper
• Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity

  2019cites this paper
• The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses

  2018cites this paper
• Treatment resistance in urothelial carcinoma: an evolutionary perspective

  2018cites this paper
• Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells

  2018cites this paper
• Perspective on the dynamics of cancer

  2017cites this paper
• Antitumor Antibodies Can Drive Therapeutic T Cell Responses.

  2017cites this paper
• Combination antitumor therapy with targeted dual‐nanomedicines☆

  2017cites this paper
• Microfluidic Encapsulation of Prickly Zinc‐Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy

  2017cites this paper
• A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine

  2016cites this paper
• Therapeutic potential of mTOR inhibitors for targeting cancer stem cells.

  2016cites this paper
• In vitro drug sensitivity in canine lymphoma

  2016cites this paper
• Biomarker Development in Targeting Cancer Epigenetic

  2016cites this paper
• A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types

  2016cites this paper
• DE G In vitro drug sensitivity in canine lymphoma

  2016cites this paper
• Mechanotransduction, Metastasis and Genomic Instability

  2015cites this paper
• Preclinical Kinetic Analysis of the Caspase-3/7 PET Tracer 18F-C-SNAT: Quantifying the Changes in Blood Flow and Tumor Retention After Chemotherapy

  2015cites this paper
• The changing world of drug development.

  2014cites this paper
• Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity

  2014cites this paper
• Simultaneous Expression of Cancer Stem Cell-Like Properties and Cancer-Associated Fibroblast-Like Properties in a Primary Culture of Breast Cancer Cells

  2014cites this paper
• Tumour heterogeneity and the evolution of polyclonal drug resistance

  2014cites this paper
• Identifying and Quantifying Heterogeneity in High Content Analysis: Application of Heterogeneity Indices to Drug Discovery

  2014cites this paper
• How Mechanotransduction Regulates Normal Cell Behavior Extracellular Factors Affecting Mechanotransduction in Normal Cells

  2014cites this paper